Cargando…
Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
Vasoplegic syndrome is a type of distributive shock characterized by mean arterial pressure of less than 65 mmHg, with normal to high cardiac output and often refractory to fluid resuscitation, high doses of intravenous vasopressors, and inotropes. It is usually observed after cardiac and solid orga...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231868/ https://www.ncbi.nlm.nih.gov/pubmed/37265888 http://dx.doi.org/10.7759/cureus.38400 |
_version_ | 1785051832365613056 |
---|---|
author | Ayasa, Laith A Azar, Jehad Odeh, Anas Ayyad, Mohammed Shbaita, Sara Zidan, Thabet Awwad, Noor Al-deen Kawa, Nagham M Awad, Wafaa |
author_facet | Ayasa, Laith A Azar, Jehad Odeh, Anas Ayyad, Mohammed Shbaita, Sara Zidan, Thabet Awwad, Noor Al-deen Kawa, Nagham M Awad, Wafaa |
author_sort | Ayasa, Laith A |
collection | PubMed |
description | Vasoplegic syndrome is a type of distributive shock characterized by mean arterial pressure of less than 65 mmHg, with normal to high cardiac output and often refractory to fluid resuscitation, high doses of intravenous vasopressors, and inotropes. It is usually observed after cardiac and solid organ transplantation surgeries. Here, we report a 56-year-old female patient who presented with a profound vasoplegia manifesting as lethargy and confusion in the setting of amlodipine toxicity. This case of severe vasoplegia was refractory to all conditional lines of medical management reported in the literature. The mainstay treatment modalities for vasoplegia include volume resuscitation, catecholamines, vasopressin, angiotensin II, and possibly methylene blue in unresponsive cases. Our patient was given hydroxocobalamin in favor of methylene blue, given the history of serotonin reuptake inhibitors use, which would have caused a life-threatening serotonin syndrome. Hydroxycobolamine resulted in a dramatic clinical recovery, suggesting its potentially significant role in refractory vasoplegia. |
format | Online Article Text |
id | pubmed-10231868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-102318682023-06-01 Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia Ayasa, Laith A Azar, Jehad Odeh, Anas Ayyad, Mohammed Shbaita, Sara Zidan, Thabet Awwad, Noor Al-deen Kawa, Nagham M Awad, Wafaa Cureus Emergency Medicine Vasoplegic syndrome is a type of distributive shock characterized by mean arterial pressure of less than 65 mmHg, with normal to high cardiac output and often refractory to fluid resuscitation, high doses of intravenous vasopressors, and inotropes. It is usually observed after cardiac and solid organ transplantation surgeries. Here, we report a 56-year-old female patient who presented with a profound vasoplegia manifesting as lethargy and confusion in the setting of amlodipine toxicity. This case of severe vasoplegia was refractory to all conditional lines of medical management reported in the literature. The mainstay treatment modalities for vasoplegia include volume resuscitation, catecholamines, vasopressin, angiotensin II, and possibly methylene blue in unresponsive cases. Our patient was given hydroxocobalamin in favor of methylene blue, given the history of serotonin reuptake inhibitors use, which would have caused a life-threatening serotonin syndrome. Hydroxycobolamine resulted in a dramatic clinical recovery, suggesting its potentially significant role in refractory vasoplegia. Cureus 2023-05-01 /pmc/articles/PMC10231868/ /pubmed/37265888 http://dx.doi.org/10.7759/cureus.38400 Text en Copyright © 2023, Ayasa et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Emergency Medicine Ayasa, Laith A Azar, Jehad Odeh, Anas Ayyad, Mohammed Shbaita, Sara Zidan, Thabet Awwad, Noor Al-deen Kawa, Nagham M Awad, Wafaa Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia |
title | Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia |
title_full | Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia |
title_fullStr | Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia |
title_full_unstemmed | Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia |
title_short | Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia |
title_sort | hydroxocobalamin as rescue therapy in a patient with refractory amlodipine-induced vasoplegia |
topic | Emergency Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231868/ https://www.ncbi.nlm.nih.gov/pubmed/37265888 http://dx.doi.org/10.7759/cureus.38400 |
work_keys_str_mv | AT ayasalaitha hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia AT azarjehad hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia AT odehanas hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia AT ayyadmohammed hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia AT shbaitasara hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia AT zidanthabet hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia AT awwadnooraldeen hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia AT kawanaghamm hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia AT awadwafaa hydroxocobalaminasrescuetherapyinapatientwithrefractoryamlodipineinducedvasoplegia |